Antidiabetic action of the mesoxalates, since reported by Kobayashi et al. (1) and Kobayashi and Ohashi (2), has been widely acknowledged and some clinical investigators [Sakaguchi et al. (3), Kurokawa et al. (4), Takeda et al. (5), Kodama (6)] have published their observations on its therapeutical evaluation for the control of diabetic patients. It is noteworthy, however, that the mesoxalates could not be pharmacologically evidenced to show any blood sugar lowering effect in normal animals. On the other hand, Take uchi (7) reported recently that some compounds possessing polycarbonyl radical in their chemical structure showed the similar effect on the glucose tolerance in rabbits with that of mesoxalates, and especially, the cyclic polycarbonyls such as trichinoyl or rhodizonic acid, were found to have the 100-fold potency when that of mesoxalates was evaluated 1 potency. According to his previous report (8), a new screening test for the mesoxalinic activity had to be established, since the mesoxalates was considered too weak to produce a hypoglycemia. The compounds, consequently, evaluated to have a strong activity by Takeuchi's method should be examined on their blood sugar lowering effect. The present communication describes the result of experiments on hypoglycemic activity of rhodizonate, trichinoyl and tetrahydroxyquinone.
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The present communication describes the result of experiments on hypoglycemic activity of rhodizonate, trichinoyl and tetrahydroxyquinone.
EXPERIMENTAL MATERIALS AND METHODS
Oral toxicity was studied with DD mice, weighing 15-20 g, which had been main tained in an animal stock room kept at temperature of 24+5`C and humidity of 50%, and given a standard diet (Oriental MF) and water both ad libitum for more than a week. The test compound, dissolved in a 0.2% CMC, was given into stomach through a gastric tube after 4-hour fasting. A group of 20 animals was used for each dose level. Another groups were subcutaneously pretreated with 1 g/kg of glucose 30 minutes before the administration of the test compound. LD50 was computed by Litchfield-Wilcoxon's method.
In the examination on the local stimulating activity, 0.1 ml of a 5% solution of the test compound in a physiological saline solution was intracutaneously injected into the ear-lobe of the rabbit, and the local reaction at 24 and 48 hours after the injection was observed by transmitting rays from the standard lamp. The reactions were assessed by the gradings as shown in Table 1 . Blood sugar lowering action was examined by the following two methods: 1) Mouse hypoglycemia test : DD mice of both sexes , weighing 15-20 g, which had been bred more than 10 days with Oriental MF diet in a stock room, conditioned as above mentioned, were used. After 5-hour fasting, the animals were divided into groups of each 6, and orally given 10% solutions of each compound in a 0 .2% CMC in 4-5 dose levels, respectively, ranging 0.31-3.1 g/kg. At 2 hours after the administration, each 0.1 ml of arterial blood was collected by cutting the carotid artery. The control group was given only a 0.2% CMC.
2) Rabbit test: Male rabbits, weighing 2-2.5 kg, given Oriental RC 5 diet and water both ad libitum for more than 10 days were used. After 16-hour fasting , the test compound was orally administered with a stomach tube in 4 dose-levels of 0 .3, 0.54, 1.0 and 1.75 g/kg. Each 0.1 ml bleeding was made from the ear-vein at 0 , 1, 2, 3, 5, 7, 9 and 24 hours after the administration of the test compound .
Blood sugar was determined by Hagedorn Jensen's method . Test compounds were dipotassium salt of tetrahydroxyquinone (THQ), dipotassium rhodizonate (RH) and trichinoyl octahydrate (TR), all of which were supplied by Research Foundation , Itsuu Laboratory ( Fig. 1 ). 
RESULTS

1) LD50 test :
For a glucose-untreated mouse, LD50 of THQ was 0 .952 g/kg (Fiducial limits: 0.884 1.094 g/kg), that of RH being 1 .125 g/kg (F.L.: 1.040-1.274 g/kg). Oral toxicity of TR was so low that a full 3.0 g/kg failed to cause death in any case . For a glucose-treated group, LD50 of THQ was 1.180 g/kg (F.L.: 1.092-1.386 g/kg), while that of RH was above 3.0 g/kg. Thus, THQ was scarcely affected by glucose pretreatment, while RH was so largely affected that death was not produced even by a larger dose than 3 g/kg.
2) Local stimulating action The results are shown in Table 1 . THQ was shown to exert relatively strong action, but RH and TR were demonstrated to have scarcely any noticeable local stimulating activity. But they took place in less than a half of the group and there was no correlation between the incidence of low blood sugar and the dose. And each group includes, among cases without blood sugar decrease , one or two cases in which blood sugar levels rose above the physiological upper limit. Table 3 gives the blood sugar levels after compound administration, and Fig. 3 re presents the average per cent decrease against the pre-administration level taken as 100.
When THQ was given in doses above 0.54 g/kg, evident decrease of blood sugar level was visible. But the rate of the decrease was lower in the 1 g/kg given group than in the 0.54 g/ kg group. Thus, in rabbits as in mice, the hypoglycemic effect was not proportional to increase in the dose. Further observation of the blood sugar decrease revealed that the initial fall was followed by a transient rise in many cases. For example, blood sugar levels in case 1 were 8 mg%, 59 mg% and 40 mg% at 3, 7 and 9 hours, respectively, and they were 66 mg%, 85 mg% and 37 mg% at 3, 5 and 9 hours in case 5, respectively. But at 24 hours, they were 70 mg% and 76 mg% in cases 1 and 5, respectively, showing tenden cy of recovery of the initial level. The average at 3 hours for the 1.75 g/kg group was 26% , indicating a marked fall. Two cases of this group died, one (case 2) at 24 hours, the other (case 1) at a week. Pathological resection of these two revealed a common feature of multi ple gastric ulcers and occasional perforations in association with panperitonitis. RH groups: RH produced evident blood sugar decrease when the dose was above 1 g/ kg. In the 1 g/kg given group, the blood sugar lowering began to appear at about 3 hours , and lasted until about 9 hours. For example, blood sugar level in case 7 showed relatively slow fall from the initial 125 mg% to the lowest 43 mg% at 7 hours, and it was 79 mg% even at 24 hours, which was significant lower than the initial level. In the 1.75 g/kg group, 59% and 43%, early fall occurred at 2 and 3 hours, respectively, but blood sugar levels transient rise at 5 and 7 hours, giving the average decrease of 64% and 93%, respectively, which were a little higher than the neighboring values. At 9 hours, the average de crease became 51 %, showing again the tendency of fall. In cases 1, 2 and 4, marked decrease was especially found; case 1 giving 0 mg% at 9 hours, case 2 giving 24 mg% at 3 hours, case 4 giving 29 mg% at 2 hours and 15 mg% at 3 hours . Thus they showed marked blood sugar decrease, but all recovered the initial 94% at 24 hours.
TR groups : TR did not exert any hypoglycemic action when the dose was below 1 g/ kg. When 1.75 g/kg was given, blood sugar showed 53% decrease at 5 hours. Blood sugar decrease after drug administration continued for 9 hours, but the initial level of 112% was restored at 24 hours.
None of RH and TR-given animals died.
DISCUSSION
Many studies, inclusive of the authors', have already been reported on pharmacolo gical actions of mesoxalates which are said useful for the control of mild diabetic patients.
And the mode of their antidiabetic actions is considered to liberate insulin from beta-cells in the pancreatic islets [Ohashi et al. (9) ]. Their actions, however, seem to be weak , since they can not lower blood sugar level in normal dogs, cats, rabbits and rats by the adminis tration through the conventional route such as intravenous, subcutaneous and oral. One of the authors, Takeuchi (7), previously discovered rhodizonate, trichinoyl and others which were demonstrated to have potency 100 times as high as mesoxalates. It is of high interest to examine what effect these compounds would exert on blood sugar of normal animals. Besides the qualitative elucidation of the mesoxalate-like action, the examination will contribute to specify the criteria in the new screening test for antidiabetic action, proposed by Takeuchi et al. (8) . Inoue (10) , one of the authors, examined SH-inhibitors and chelating agents to find some of them being positive in this test. For example, N ethyl maleimide derivatives, PCMB and anthranilic acid derivatives were such positive compounds. It is, however, hardly possible to assume that all of them are antidiabetic. Rhodizonate and trichinoyl, which were examined in this paper, not only have r nesoxalinic action and SH-inhibiting action [Seris (11, 12) ], but also are resemble to mesoxalic acid in the chemical structure, that is, the possession of the polycarbonyl radical. Unlike them, tetrahydroxyquinone does not possess polycarbonyl radical in its chemical structure, but nevertheless it was together taken up in the present experiment, since, being unstable in aqueous solution, it is chemically assumed to be partially oxidized into rhodizonic acid [Seris (13, 14) ]. The acute toxicity test in mice revealed that THQ and RH had nearly the same oral LD50 while TR had much higher one. But while mice were perfectly protected by 1 g/kg of glucose from acute death due to RH, this was not the case with THQ. This means that the death after a large dose of RH may be attributed to its hypoglycemic action, whereas the acute toxicity of THQ may be something other than hypoglycemic action. It was impossible in the present experiment to specify the cause of acute death of mice after THQ administration, but some clue will be given by findings of cases which died incidentally during the rabbit test and by results of examination for the local stimulating action. It was disclosed by the resection that numerous large and small ulcers involved almost the whole gastric mucosa without any prediction for either the cardia, or body or pylorus. Especially a case which died at a week after the drug administration showed additionally perforations 3-5 mm in diameter at 5 sites, and was consequently assumed to have died in panperitonitic state. It was considered that THQ, when given orally, would exert its violent local stimulating action on the gastric mucosa. Also in the hypoglycemia test with mice, a finding of interest was obtained after THQ administration. It seems not unreasonable in any way to assume that nearly the same mechanism may be underlying the hypoglycemic actions of RH and TR, because their dose-response curves were paralell with each other, although the minimum effective dose of the former ranged between 0.3 g/kg and 0.54 g/kg, whereas that of the latter was 5-10 times higher than the former. In contrast with this, hypoglycemic action of THQ was dose-independent, and even hyperglycemia was occasionally produced by its administration. Essentially, almost the same tendency was observed in the rabbit test as in the mouse hy poglycemia test: The minimum effective dose in rabbits of RH ranged between 0.54 g/ kg and 1 g/kg, and that of TR was 1.75 g/kg, while the hypoglycemic action of THQ was not always dose-respondent, although its doses above 0.54 g/kg produced hypoglycemia.
Two hypotheses can be considered for explaining the contradictory action of THQ on blood sugar level. The first is that THQ is by its self ineffective on blood sugar level, but some substance-most probably rhodizonic acid [Beilstein (15) ]-which is produced from it in the body is effective on carbohydrate metabolism. According to this, the active substance produced from it in the body may vary in the yield depending on the condition of the animal, and thus the inconsistent action of THQ can well be explained. However, this active substance must have higher potency than rhodizonic acid, because, as demon strated in the mouse hypoglycemia test, THQ produced appreciable decrease of blood sugar level in some cases in a dose level (0.3 g/kg), which is lower than the minimum effec tive dose of RH. But such a substance is not known for the moment. According to Take uchi (7) , THQ is 1 / 10 as low as RH in potency when compared by the intravenous glucose tolerance curve for rabbit. This ratio seems to be one of evidences sufficient to affirm the plausibility of this hypothesis, that is, THQ given intravenously into rabbit transforms to one tenth amount of RH. But this can not explain why THQ given orally is stronger than RH administered through the same route. At the same time, it raises a question as to whether the hypoglycemic and glucose tolerance improving actions of THQ would re present two different action modes.
According to this second hypothesis, 1) THQ has both hyper and hypoglycemic ac tions, and the inconsistency of its action consists in that either one or the other is manifested depending on a certain factor, which is not known yet; and 2) the mode of hypoglycemic action of THQ is perfectly different from that of RH. The second seems to have much higher plausibility. One of the suspection resulting from this view point, is that the hy poglycemic action of THQ should be in no way a significant antidiabetic action. It was thus concluded that considering its acute toxicity and its intense local stimulating action, this compound should not be applicable to human clinic. As known widely, THQ was already used as an inhibitor on growth of granulation in dermatologic clinic and its doses was 0.03-0.06 g/day, which was considered too low to produce any blood sugar responses or any adverse reactions [Kelly and Pinkus (16) ].
RH and TR manifested nearly the same tendency of action, though the former being 3-5 times as strong as the latter. Takeuchi (7) reported that when intravenously injected for 5 consecutive days, both gave 1 mg/kg as the minimum effective dose. In the present experiment there was difference between them, which was assumed to have resulted from difference in their chemical stability or absorbability in the intestinal tract [Fujimoto (17) ]. From the results of the present experiment, it can naturally be supposed that rhodizonate is the most suitable compound to be used as oral antidiabetics. RH had previously been recommended to antihypertensive drug and it, however, had never been reported that this drug was clinically harmful. This fact was considered to suggest a possibility that RH can be applied to diabetic patients without producing serious side effect. SUMMARY Effect of dipotassium salt of tetrahydroxyquinone (THQ), dipotassium rhodizonate (RH) and trichinoyl octahydrate (TR) was studied by using mice and rabbits. The min imum hypoglycemic doses of RH and TR given orally mice and rabbits were 0.54-1 g/kg and 1.75 g/kg, respectively, while that of THQ could not be determined. And LD50 per os for THQ, RH and TR were 0.884-1.094 g/kg, 1.041-1.274 g/kg and 3.0 g/kg, respec tively. Subcutaneous injection of 1 g/kg of glucose could protect the acute death of mice after administration with RH, but this treatment was ineffective on LD50 for THQ. Mode of hypoglycemic action of THQ was concluded to differ from those of RH and TR, which were considered similar with that of the mesoxalate.
